COO · Cooper Companies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | - | $1.06B | $1.00B | $964.70M | - | $1.00B | $942.60M | $931.60M | - |
| Cost of Revenue | $328.90M | - | $368.30M | $323.20M | $304.50M | - | $339.80M | $311.40M | $307.80M | - |
| Gross Profit | $695.20M | - | $692.00M | $679.10M | $660.20M | - | $663.00M | $631.20M | $623.80M | - |
| R&D | $44.30M | - | $44.60M | $45.50M | $40.70M | - | $39.00M | $38.90M | $39.50M | - |
| SG&A | $390.20M | - | $421.70M | $399.00M | $387.90M | - | $381.10M | $380.30M | $380.90M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $95.50M | - | - | - | $91.00M | - | - | - | $96.80M | - |
| Operating Income | $212.80M | - | $175.70M | $184.80M | $182.00M | - | $192.50M | $161.70M | $153.10M | - |
| Interest Expense | $22.40M | - | $25.40M | $28.90M | $29.90M | - | $28.50M | $28.90M | $29.90M | - |
| Income Tax | $61.40M | - | $53.60M | $56.80M | $49.00M | - | $59.00M | $41.10M | $38.80M | - |
| Net Income | $130.80M | - | $98.30M | $87.70M | $104.30M | - | $104.70M | $88.90M | $81.20M | - |
| EPS - Basic | $0.67 | - | $0.49 | $0.44 | $0.52 | - | $0.53 | $0.45 | $0.41 | - |
| EPS - Diluted | $0.66 | - | $0.49 | $0.44 | $0.52 | - | $0.52 | $0.44 | $0.41 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124.90M | $110.60M | $124.90M | $116.20M | $100.90M | $107.60M | $109.70M | $112.40M | $135.20M | $120.80M |
| Accounts Receivable | $807.10M | $829.00M | $792.30M | $780.90M | $716.40M | $717.00M | $739.00M | $688.70M | $651.00M | $609.70M |
| Inventory | $876.40M | $846.00M | $881.00M | $880.30M | $842.90M | $802.70M | $779.30M | $775.40M | $747.50M | $735.60M |
| Accounts Payable | $225.80M | $300.40M | $255.90M | $244.20M | $201.50M | $260.50M | $222.00M | $230.70M | $202.30M | $261.90M |
| Current Assets | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | $1.70B |
| Total Assets | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B |
| Current Liabilities | $1.60B | $1.11B | $1.01B | $1.01B | $999.60M | $1.02B | $969.50M | $952.50M | $964.90M | $969.00M |
| Long-term Debt | $1.88B | $2.46B | $2.43B | $2.52B | $2.49B | $2.55B | $2.59B | $2.67B | $2.72B | $2.52B |
| Total Liabilities | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | $4.11B |
| Stockholders' Equity | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | $7.55B |
| Retained Earnings | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | $6.88B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $260.90M | - | - | - | $190.60M | - | - | - | $122.70M | - |
| Investing Cash Flow | ($102.90M) | - | - | - | ($96.80M) | - | - | - | ($324.10M) | - |
| Financing Cash Flow | ($147.90M) | - | - | - | ($96.60M) | - | - | - | $212.30M | - |
| CapEx | $102.20M | - | - | - | $89.40M | - | - | - | $118.10M | - |
| Free Cash Flow | $158.70M | - | - | - | $101.20M | - | - | - | $4.60M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 67.9% | - | 65.3% | 67.8% | 68.4% | - | 66.1% | 67.0% | 67.0% | - |
| Operating margin | 20.8% | - | 16.6% | 18.4% | 18.9% | - | 19.2% | 17.2% | 16.4% | - |
| EBITDA margin | 30.1% | - | - | - | 28.3% | - | - | - | 26.8% | - |
| Net margin | 12.8% | - | 9.3% | 8.7% | 10.8% | - | 10.4% | 9.4% | 8.7% | - |
| Free cash flow margin | 15.5% | - | - | - | 10.5% | - | - | - | 0.5% | - |
| FCF / Net income | 1.21 | - | - | - | 0.97 | - | - | - | 0.06 | - |
| R&D / Revenue | 4.3% | - | 4.2% | 4.5% | 4.2% | - | 3.9% | 4.1% | 4.2% | - |
| SG&A / Revenue | 38.1% | - | 39.8% | 39.8% | 40.2% | - | 38.0% | 40.3% | 40.9% | - |
| Effective tax rate | 31.9% | - | 35.3% | 39.3% | 32.0% | - | 36.0% | 31.6% | 32.3% | - |
| Return on assets | 1.1% | - | 0.8% | 0.7% | 0.9% | - | 0.9% | 0.7% | 0.7% | - |
| Return on equity | 1.6% | - | 1.2% | 1.1% | 1.3% | - | 1.3% | 1.1% | 1.1% | - |
| Return on invested capital | 1.4% | - | 1.1% | 1.0% | 1.2% | - | 1.2% | 1.1% | 1.0% | - |
| Liquidity | ||||||||||
| Current ratio | 1.34 | 1.89 | 2.12 | 2.10 | 1.99 | 1.91 | 1.99 | 1.95 | 1.86 | 1.76 |
| Quick ratio | 0.79 | 1.13 | 1.24 | 1.23 | 1.14 | 1.12 | 1.18 | 1.14 | 1.08 | 1.00 |
| Cash ratio | 0.08 | 0.10 | 0.12 | 0.11 | 0.10 | 0.11 | 0.11 | 0.12 | 0.14 | 0.12 |
| Leverage | ||||||||||
| Debt / Equity | 0.22 | 0.30 | 0.29 | 0.30 | 0.31 | 0.32 | 0.33 | 0.34 | 0.35 | 0.33 |
| Debt / Assets | 0.15 | 0.20 | 0.20 | 0.20 | 0.20 | 0.21 | 0.21 | 0.22 | 0.23 | 0.22 |
| Debt / EBITDA | 6.09 | - | - | - | 9.12 | - | - | - | 10.90 | - |
| Interest coverage | 9.5x | - | 6.9x | 6.4x | 6.1x | - | 6.8x | 5.6x | 5.1x | - |
| Equity multiplier | 1.49 | 1.50 | 1.48 | 1.50 | 1.50 | 1.52 | 1.53 | 1.54 | 1.56 | 1.54 |
| Liabilities / Assets | 0.33 | 0.34 | 0.33 | 0.33 | 0.34 | 0.34 | 0.35 | 0.35 | 0.36 | 0.35 |
| Efficiency | ||||||||||
| Asset turnover | 0.08 | - | 0.09 | 0.08 | 0.08 | - | 0.08 | 0.08 | 0.08 | - |
| Inventory turnover | 0.38 | - | 0.42 | 0.37 | 0.36 | - | 0.44 | 0.40 | 0.41 | - |
| Days sales outstanding | 288d | - | 273d | 284d | 271d | - | 269d | 267d | 255d | - |
| Days inventory outstanding | 973d | - | 873d | 994d | 1010d | - | 837d | 909d | 886d | - |
| Days payable outstanding | 251d | - | 254d | 276d | 242d | - | 238d | 270d | 240d | - |
| Cash conversion cycle | 1010d | - | 892d | 1003d | 1040d | - | 868d | 905d | 902d | - |
| Valuation | ||||||||||
| P / E | 123.3x | - | 144.3x | 185.6x | 185.7x | - | 179.5x | 202.4x | 227.5x | - |
| P / B | 1.9x | - | 1.7x | 2.0x | 2.4x | - | 2.4x | 2.3x | 2.4x | - |
| P / S | 15.6x | - | 13.3x | 16.4x | 20.1x | - | 18.7x | 18.9x | 20.0x | - |
| EV / EBITDA | 57.6x | - | - | - | 79.9x | - | - | - | 85.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 6.2% | - | 5.7% | 6.3% | 3.6% | - | 7.8% | 7.4% | 8.5% | - |
| Revenue CAGR (3y) | 6.1% | - | 7.9% | 6.5% | 7.0% | - | 9.5% | 9.4% | 11.0% | - |
| Revenue CAGR (5y) | 8.5% | - | 12.9% | 13.8% | 8.3% | - | 8.7% | 7.6% | 8.2% | - |
| Gross profit growth (YoY) | 5.3% | - | 4.4% | 7.6% | 5.8% | - | 8.7% | 8.3% | 11.7% | - |
| Operating income growth (YoY) | 16.9% | - | -8.7% | 14.3% | 18.9% | - | 27.0% | 67.9% | 2.4% | - |
| Net income growth (YoY) | 25.4% | - | -6.1% | -1.3% | 28.4% | - | 22.7% | 123.4% | -4.0% | - |
| EPS growth (YoY) | 26.9% | - | -5.8% | 0.0% | 26.8% | - | -69.6% | -45.0% | -75.9% | - |
| EPS CAGR (3y) | -27.0% | - | -37.2% | -44.3% | -35.2% | - | -65.2% | -42.9% | -78.7% | - |
| EPS CAGR (5y) | -56.5% | - | -15.2% | 13.9% | -22.2% | - | -26.4% | -29.1% | -27.7% | - |
| FCF growth (YoY) | 56.8% | - | - | - | 2100.0% | - | - | - | -94.5% | - |
| FCF CAGR (5y) | 11.6% | - | - | - | 10.8% | - | - | - | -27.3% | - |
| Book value growth (YoY) | 2.9% | 1.9% | 5.4% | 6.2% | 5.6% | 7.1% | 5.3% | 5.8% | 4.9% | 5.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-10-31.
Business segments
$8.18B totalCooper Vision Segment$2.74B · 33.5%
Coopervision Segment$2.74B · 33.5%
Cooper Surgical Segment$1.35B · 16.5%
Coopersurgical Segment$1.35B · 16.5%
Product / service
$4.09B totalSphere Other$1.39B · 34.0%
Toric And Multifocal$1.35B · 33.0%
Office And Surgical$824.00M · 20.1%
Fertility$524.60M · 12.8%
Geographic
$4.09B totalUS$2.05B · 50.2%
Europe$1.25B · 30.6%
Rest Of The World$785.20M · 19.2%
Peer comparison
Same SIC group: Ophthalmic Goods
Comparing COOPER COMPANIES against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Jul 26, 2023 | $0.0075 |
| Jan 20, 2023 | $0.0075 |
| Jul 26, 2022 | $0.0075 |
| Jan 20, 2022 | $0.0075 |
| Jul 26, 2021 | $0.0075 |
| Jan 21, 2021 | $0.0075 |
| Jul 22, 2020 | $0.0075 |
| Jan 22, 2020 | $0.0075 |
| Jul 22, 2019 | $0.0075 |
| Jan 18, 2019 | $0.0075 |
| Jul 20, 2018 | $0.0075 |
| Jan 22, 2018 | $0.0075 |
| Jul 19, 2017 | $0.0075 |
| Jan 19, 2017 | $0.0075 |
| Jul 20, 2016 | $0.0075 |
| Jan 20, 2016 | $0.0075 |
| Jul 22, 2015 | $0.0075 |
| Jan 21, 2015 | $0.0075 |
| Jul 22, 2014 | $0.0075 |
| Jan 22, 2014 | $0.0075 |
| Jul 22, 2013 | $0.0075 |
| Jan 23, 2013 | $0.0075 |
| Jul 20, 2012 | $0.0075 |
| Jan 23, 2012 | $0.0075 |